Variation in antiretroviral treatment coverage and virological suppression among three HIV key populations.
Average rating
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Star rating
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Authors
Laut, Kamilla GrønborgShepherd, Leah
Gottfredsson, Magnus
Sedlacek, Dalibor
Knysz, Brygida
Begovac, Josip
Radoi, Roxana
Schmied, Brigitte
Chkhartishvili, Nikoloz
Florence, Eric
Ristola, Matti
Fätkenheuer, Gerd
Mulcahy, Fiona
Schmid, Patrick
Kuzovatova, Elena
Paduta, Dzmitry
Smidt, Jelena
Domingo, Pere
Szlávik, Janos
Lundgren, Jens
Mocroft, Amanda
Kirk, Ole
Issue Date
2018-11-28
Metadata
Show full item recordCitation
Variation in antiretroviral treatment coverage and virological suppression among three HIV key populations. 2018, 32(18):2807-2819 AIDSAbstract
We assessed differences in antiretroviral treatment (ART) coverage and virological suppression across three HIV key populations, as defined by self-reported HIV transmission category: sex between men, injection drug use (IDU) and heterosexual transmission. A multinational cohort study. Within the EuroSIDA study, we assessed region-specific percentages of ART-coverage among those in care and virological suppression (<500 copies/ml) among those on ART, and analysed differences between transmission categories using logistic regression. Among 12 872 participants followed from 1 July 2014 to 30 June 2016, the percentages of ART-coverage and virological suppression varied between transmission categories, depending on geographical region (global P for interaction: P = 0.0148 for ART-coverage, P = 0.0006 for virological suppression). In Western [adjusted odds ratio (aOR) 1.41 (95% confidence interval 1.14-1.75)] and Northern Europe [aOR 1.68 (95% confidence interval 1.25-2.26)], heterosexuals were more likely to receive ART than MSM, while in Eastern Europe, there was some evidence that infection through IDU [aOR 0.60 (95% confidence interval 0.31-1.14)] or heterosexual contact [aOR 0.58 (95% confidence interval 0.30-1.10)] was associated with lower odds of receiving ART. In terms of virological suppression, people infected through IDU or heterosexual contact in East Central and Eastern Europe were around half as likely as MSM to have a suppressed viral load on ART, while we observed no differences in virological suppression across transmission categories in Western and Northern Europe.Description
To access publisher's full text version of this article click on the hyperlink belowAdditional Links
https://journals.lww.com/aidsonline/Abstract/2018/11280/Variation_in_antiretroviral_treatment_coverage_and.16.aspxae974a485f413a2113503eed53cd6c53
10.1097/QAD.0000000000002035
Scopus Count
Collections
Related articles
- Persistent disparities in antiretroviral treatment (ART) coverage and virological suppression across Europe, 2004 to 2015.
- Authors: Laut K, Shepherd L, Radoi R, Karpov I, Parczewski M, Mussini C, Maltez F, Losso M, Chkhartishvili N, Elinav H, Kovari H, Blaxhult A, Zangerle R, Trofimova T, Inglot M, Zilmer K, Kuzovatova E, Staub T, Raben D, Lundgren J, Mocroft A, Kirk O, On Behalf Of The EuroSIDA Study Group
- Issue date: 2018 May
- Clinical outcomes of patients infected with HIV through use of injected drugs compared to patients infected through sexual transmission: late presentation, delayed anti-retroviral treatment and higher mortality.
- Authors: Suárez-García I, Sobrino-Vegas P, Dalmau D, Rubio R, Iribarren JA, Blanco JR, Gutierrez F, Montero Alonso M, Bernal E, Vinuesa García D, Del Amo J, Cohort of the Spanish HIV Research Network (CoRIS).
- Issue date: 2016 Jul
- Very low level viraemia and risk of virological failure in treated HIV-1-infected patients.
- Authors: Teira R, Vidal F, Muñoz-Sánchez P, Geijo P, Viciana P, Ribera E, Domingo P, Castaño M, Martínez E, Roca B, Puig T, Estrada V, Deig E, Galindo MJ, de la Fuente B, Lozano F, Montero M, Muñoz-Sanz A, Sanchez T, Terrón A, Romero-Palacios A, Lacalle JR, Garrido M, Suárez-Lozano I, VACH Study Group.
- Issue date: 2017 Mar
- Adoption of routine virologic testing and predictors of virologic failure among HIV-infected children on antiretroviral treatment in western Kenya.
- Authors: Kadima J, Patterson E, Mburu M, Blat C, Nyanduko M, Bukusi EA, Cohen C, Oyaro P, Abuogi L
- Issue date: 2018
- Higher rates of triple-class virological failure in perinatally HIV-infected teenagers compared with heterosexually infected young adults in Europe.
- Authors: Judd A, Lodwick R, Noguera-Julian A, Gibb DM, Butler K, Costagliola D, Sabin C, van Sighem A, Ledergerber B, Torti C, Mocroft A, Podzamczer D, Dorrucci M, De Wit S, Obel N, Dabis F, Cozzi-Lepri A, García F, Brockmeyer NH, Warszawski J, Gonzalez-Tome MI, Mussini C, Touloumi G, Zangerle R, Ghosn J, Castagna A, Fätkenheuer G, Stephan C, Meyer L, Campbell MA, Chene G, Phillips A, Pursuing Later Treatment Options II (PLATO II) Project Team for the Collaboration of Observational HIV Epidemiological Research Europe (COHERE) in EuroCoord.
- Issue date: 2017 Mar